Fundraising Fox

Cellarity

Founded 2017 · 66 employees on LinkedIn · 4 known investors

Cellarity develops medicines using artificial intelligence and single-cell biology to address disease at the cellular level rather than targeting individual disease markers. The company serves patients with challenging diseases through AI-driven drug discovery.

AI & Machine LearningBiotechDeep TechMedical Devices

Investors · 4

Ahren Innovation CapitalCambridge, Cambridgeshire
Flagship PioneeringCambridge · $500K – $10M
Manta Ray VenturesLondon
BlackRockreportedWilmington

Funding

SEC filings, press & company announcements

$121M disclosed across 1 of 2 rounds · 2022–2024

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

4 people who came through Cellarity went on to found or lead other companies.

Noubar AfeyanCo-Founder and ChairmanFounded ProFound Therapeutics +12Avak KahvejianFounding CEOFounded ProFound Therapeutics +4Alex WolfConsultant, Machine LearningFounded LaminSunny SunSenior Scientist, Computational BiologyFounded Lamin

In the news

Cellarity Secures $121M in Series C Funding to Revolutionize Drug Discovery | Signalbasetrysignalbase.com · Nov 2024Flagship-founded Cellarity tacks on $121M series C to fund cell behaviour pipelinefiercebiotech.com · Oct 2022Cellarity Closes $121M Series C Financingfinsmes.com · Oct 2022Cellarity, Flagship startup that aims to treat 'any disease,' raises $123M - Boston Business Journalbizjournals.com · Feb 2021Cellarity Raises $123M in Series B Funding - FinSMEsfinsmes.com · Feb 2021Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Targetprnewswire.com · Feb 2021

Frequently asked questions

What does Cellarity do?
Cellarity develops medicines using artificial intelligence and single-cell biology to address disease at the cellular level rather than targeting individual disease markers. The company serves patients with challenging diseases through AI-driven drug discovery.
Who are Cellarity's investors?
Cellarity's investors include Ahren Innovation Capital, Flagship Pioneering, Manta Ray Ventures, BlackRock.
How much funding has Cellarity raised?
Cellarity has disclosed $121M raised across 1 of its 2 known rounds.